Home/Filings/4/0001103021-22-000053
4//SEC Filing

Bailey Jeffrey Allen 4

Accession 0001103021-22-000053

CIK 0001103021other

Filed

Mar 10, 7:00 PM ET

Accepted

Mar 11, 8:08 AM ET

Size

7.0 KB

Accession

0001103021-22-000053

Insider Transaction Report

Form 4
Period: 2022-03-09
Bailey Jeffrey Allen
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2022-03-09+5,333105,133 total
  • Exercise/Conversion

    Restricted Stock Units

    2022-03-095,3335,334 total
    Exercise: $0.00Exp: 2023-03-08Common Stock (5,333 underlying)
Footnotes (1)
  • [F1]The shares of common stock were acquired by the Reporting Person as a result of the vesting of 5,333 of RSUs granted to the Reporting Person on March 9, 2020 under the Issuer's 2019 Stock Option Incentive Plan. The remainder of the RSUs under this grant will vest on March 9, 2023.

Issuer

BIODELIVERY SCIENCES INTERNATIONAL INC

CIK 0001103021

Entity typeother

Related Parties

1
  • filerCIK 0001500210

Filing Metadata

Form type
4
Filed
Mar 10, 7:00 PM ET
Accepted
Mar 11, 8:08 AM ET
Size
7.0 KB